A Brief Review on Recent Lab-on-Chip and Nanotechnology driven advances in Salivary Biomarkers Biosensing for oral disease diagnosis

02 May 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Salivary diagnostics offers a promising method for early diagnosis, prognosis, and post-therapy monitoring. Saliva contains various hormones, proteins, enzymes, antibodies, antimicrobial constituents, and cytokines that can provide diagnostic information. Saliva is easy to collect, non- invasive, cost-effective, and can be easily stored and transported, making it a valuable tool for diagnosis and monitoring of various diseases. Salivary biomarkers can be used for early detection, diagnosis, and monitoring of disease progression, as well as predicting treatment response. Saliva has been identified as a promising diagnostic fluid for detecting various oral diseases such as dental caries, periodontal disease, and oral cancer. This review explores the latest advancements in identifying biomarkers for prevalent oral diseases and the biosensing technologies that can detect these biomarkers with enhanced sensitivity, selectivity, accuracy, and practicality.

Keywords

Salivary biomarkers
Oral disease
Bioassay

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.